The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Assessing the Diagnostic Properties of a Graded Oral Provocation Challenge for the Diagnosis of Immediate and Nonimmediate Reactions to Amoxicillin in Children
Open accessAbstract
IMPORTANCE: The diagnostic properties of a graded provocation challenge (PC) among children presenting with a rash in the course of amoxicillin treatment are currently unknown. OBJECTIVE: To assess the accuracy and the negative predictive value of the PC in a cohort of children referred with suspected allergy to amoxicillin. DESIGN, SETTING, AND PARTICIPANTS: A cohort study was conducted between March 1, 2012, and April 1, 2015, at the allergy clinic of the Montreal Children's Hospital, Montreal, Quebec, Canada. All children referred with suspected allergy to amoxicillin were approached. In addition, 346 eligible children were followed up to assess reactions to subsequent use of amoxicillin at the time of illness in cases with negative PC results. Data were collected on clinical characteristics, suspected antibiotic exposure, personal and first-degree relatives' comorbidities, and history of atopy and management of the reaction. Univariate and multivariate logistic regressions were compared to determine factors associated with immediate and nonimmediate reactions to the PC. INTERVENTIONS: All children had a graded PC. MAIN OUTCOMES AND MEASURES: Reactions to the graded PC, the negative predictive value of the PC for nonimmediate reactions, and factors associated with immediate and nonimmediate reactions to the PC. RESULTS: A total of 818 children were assessed (median age, 1.7 years [interquartile range, 1.0-3.9 years]; 441 [53.9%] male). Among all participants, 770 (94.1%) tolerated the PC, 17 (2.1%) developed mild immediate reactions, and 31 (3.8%) developed nonimmediate reactions. The graded PC had a specificity of 100.0% (95% CI, 90.9%-100.0%), a negative predictive value of 89.1% (95% CI, 77.1%-95.5%), and a positive predictive value of 100.0% (95% CI, 86.3%-100.0%). Among all 346 participants eligible for annual follow-up, 250 (72.3%; 95% CI, 67.2%-76.8%) responded, 55 of whom received subsequent full treatment with amoxicillin; 49 of these 55 participants (89.1%) reported tolerance to subsequent full treatment with amoxicillin, while 6 (10.9%) developed nonimmediate cutaneous reactions. History of a reaction occurring within 5 minutes of exposure was associated with immediate reactions to the PC (adjusted odds ratio = 9.6; 95% CI, 1.5-64.0), while a rash that lasted longer than 7 days (adjusted odds ratio = 4.8; 95% CI, 1.4-16.4) and parental history of drug allergy (adjusted odds ratio = 3.0; 95% CI, 1.3-6.8) were associated with nonimmediate reactions to the PC. CONCLUSIONS AND RELEVANCE: Graded PCs provide an accurate and safe confirmatory test for skin-related reactions to amoxicillin. Further studies are required to assess factors associated with the PC outcome groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Bock, S. A., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.12.1303 · Cited by 2,313
International Con sensus on drug allergy
Demoly, P., Adkinson, N. F., Brockow, K., Castells, M., Chiriac, A. M., Greenberger, P. A., Khan, D. A., Lang, D. M., Park, H. ‐., Pichler, W., et al. (2014) · Allergy · doi:10.1111/all.12350 · Cited by 935
Sampson, H. A., Muñoz-Furlong, A., Campbell, R. L., Adkinson, N. F., Allan Bock, S., Branum, A., Brown, S. G. A., Camargo, C. A., Cydulka, R., Galli, S. J., et al. (2006) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2006.01.018 · Cited by 748
Delayed Drug Hypersensitivity Reactions
Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 735
Antibiotics for acute otitis media in children
Venekamp, R. P., Sanders, S. L., Glasziou, P. P., Del Mar, C. B., & Rovers, M. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000219.pub4 · Cited by 620
Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media
Heikkinen, T., Thint, M., & Chonmaitree, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901283400402 · Cited by 524
Immediate Hypersensitivity Reactions to Beta-Lactam Antibiotics
SAXON, A., BEALL, G. N., ROHR, A. S., & ADELMAN, D. C. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-107-2-204 · Cited by 412
Caubet, J.-C., Kaiser, L., Lemaître, B., Fellay, B., Gervaix, A., & Eigenmann, P. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.08.025 · Cited by 345
Coker, T. R., Chan, L. S., Newberry, S. J., Limbos, M. A., Suttorp, M. J., Shekelle, P. G., & Takata, G. S. (2010) · JAMA · doi:10.1001/jama.2010.1651 · Cited by 277
Macy, E., & Ngor, E. W. (2013) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.02.002 · Cited by 275
Cited by
Evaluation and Management of Penicillin Allergy: A Review
Shenoy, E. S., Macy, E., Rowe, T., & Blumenthal, K. G. (2019) · JAMA · doi:10.1001/jama.2018.19283 · Cited by 830
Blumenthal, K. G., Peter, J. G., Trubiano, J. A., & Phillips, E. J. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32218-9 · Cited by 614
“[108] However, despite a negative IgE allergy evaluation, approximately 3% of adult patients and up to 10% in pediatric patients[61] could have a benign, delayed, possibly T-cell-mediated eruption to the drug.”
BackgroundInfluentialDrug allergy: A 2022 practice parameter update
Khan, D. A., Banerji, A., Blumenthal, K. G., Phillips, E. J., Solensky, R., White, A. A., Bernstein, J. A., Chu, D. K., Ellis, A. K., Golden, D. B. K., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.08.028 · Cited by 563
The impact of a reported penicillin allergy on surgical site infection risk.
Blumenthal, K. G., Ryan, E. E., Li, Y., Lee, H., Kuhlen, J. L., & Shenoy, E. S. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix794 · Cited by 481
“Alternative approaches may include implementation of perioperative test dose challenges to cefazolin for patients with mild and/or remote penicillin allergy histories, an approach successfully used among hospitalized [57, 58] and ambulatory [59, 60] patients.”
BackgroundTowards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper
Romano, A., Atanaskovic‐Markovic, M., Barbaud, A., Bircher, A. J., Brockow, K., Caubet, J., Celik, G., Cernadas, J., Chiriac, A., Demoly, P., et al. (2020) · Allergy · doi:10.1111/all.14122 · Cited by 361
Castells, M., Khan, D. A., & Phillips, E. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807761 · Cited by 270
The challenge of de‐labeling penicillin allergy
Stone, C. A., Trubiano, J., Coleman, D. T., Rukasin, C. R. F., & Phillips, E. J. (2020) · Allergy · doi:10.1111/all.13848 · Cited by 266
Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing.
Iammatteo, M., Alvarez Arango, S., Ferastraoaru, D., Akbar, N., Lee, A. Y., Cohen, H. W., & Jerschow, E. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2018.05.008 · Cited by 157
Who needs penicillin allergy testing?
Macy, E., & Vyles, D. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2018.07.041 · Cited by 76
Solensky, R., Jacobs, J., Lester, M., Lieberman, P., McCafferty, F., Nilsson, T., Park, M., Schwarz, G., Soong, W., Wagelie-Steffen, A., et al. (2019) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2019.02.040 · Cited by 70
Metadata
- Authors
- Mill, C., Primeau, M.-N., Medoff, E., Lejtenyi, C., O’Keefe, A., Netchiporouk, E., Dery, A., & Ben-Shoshan, M.
- Venue
- JAMA Pediatrics
- Publisher
- American Medical Association (AMA)
- Published
- 2016-06-06
- Volume
- 170
- Issue
- 6
- Pages
- e160033
- ISSN
- 1072-4710 (ISSN-L)
- 2168-6203
- OpenAlex
- W2332398369
- Cited by
- 302
- References
- 36
- FWCI
- 23.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.